Prostatic Cancer

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

Cleaning the Biopsy Needle in TRUS Bx

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

Fusion Versus Cognitive MRI Targeted Prostatic Biopsy

Dynamic Whole Body PET/ MRI

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Contribution of the VERITON-CT Camera in Prostate Bone Radiostereotaxy

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES)

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

68Ga-labeled NY108 PET Imaging in Patients

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC